View Item 

Show simple item record

Time‐varying survival effects for squamous cell carcinomas at oropharyngeal and nonoropharyngeal head and neck sites in the United States, 1973‐2015

dc.contributor.authorBrouwer, Andrew F.
dc.contributor.authorHe, Kevin
dc.contributor.authorChinn, Steven B.
dc.contributor.authorMondul, Alison M.
dc.contributor.authorChapman, Christina H.
dc.contributor.authorRyser, Marc D.
dc.contributor.authorBanerjee, Mousumi
dc.contributor.authorEisenberg, Marisa C.
dc.contributor.authorMeza, Rafael
dc.contributor.authorTaylor, Jeremy M. G.
dc.date.accessioned2020-12-02T14:37:56Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2020-12-02T14:37:56Z
dc.date.issued2020-12-01
dc.identifier.citationBrouwer, Andrew F.; He, Kevin; Chinn, Steven B.; Mondul, Alison M.; Chapman, Christina H.; Ryser, Marc D.; Banerjee, Mousumi; Eisenberg, Marisa C.; Meza, Rafael; Taylor, Jeremy M. G. (2020). "Time‐varying survival effects for squamous cell carcinomas at oropharyngeal and nonoropharyngeal head and neck sites in the United States, 1973‐2015." Cancer 126(23): 5137-5146.
dc.identifier.issn0008-543X
dc.identifier.issn1097-0142
dc.identifier.urihttps://hdl.handle.net/2027.42/163580
dc.publisherSpringer
dc.publisherWiley Periodicals, Inc.
dc.subject.otherhazard model
dc.subject.otherhead and neck cancer
dc.subject.otherhuman papillomavirus
dc.subject.otheroropharynx cancer
dc.subject.othersurvival analysis
dc.titleTime‐varying survival effects for squamous cell carcinomas at oropharyngeal and nonoropharyngeal head and neck sites in the United States, 1973‐2015
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163580/3/cncr33174_am.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163580/2/cncr33174.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163580/1/cncr33174-sup-0001-FigS1-S4.pdfen_US
dc.identifier.doi10.1002/cncr.33174
dc.identifier.sourceCancer
dc.identifier.citedreferenceAndreassen BK, Grimsrud TK, Haug ES. Bladder cancer survival: women better off in the long run. Eur J Cancer. 2018; 95: 52 ‐ 58.
dc.identifier.citedreferenceJanz TA, Graboyes EM, Nguyen SA, et al. A comparison of the NCDB and SEER database for research involving head and neck cancer. Otolaryngol Head Neck Surg. 2019; 160: 284 ‐ 294.
dc.identifier.citedreferenceSurveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov). SEER*Stat Database: Incidence ‐ SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2017 Sub (1973‐2015 varying) ‐ Linked To County Attributes ‐ Total U.S., 1969‐2016 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2018, based on the November 2017 submission..
dc.identifier.citedreferenceHowlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of cancer‐specific survival rates from population‐based data. J Natl Cancer Inst. 2010; 102: 1584 ‐ 1598.
dc.identifier.citedreferenceChaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus–related and –unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008; 26: 612 ‐ 619.
dc.identifier.citedreferenceChaturvedi AK, Anderson WF, Lortet‐Tieulent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013; 31: 4550 ‐ 4559.
dc.identifier.citedreferenceSatagopan JM, Ben‐Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer. 2004; 91: 1229 ‐ 1235.
dc.identifier.citedreferenceHaller B, Schmidt G, Ulm K. Applying competing risks regression models: an overview. Lifetime Data Anal. 2013; 19: 33 ‐ 58.
dc.identifier.citedreferenceHowlader N, Mariotto AB, Woloshin S, Schwartz LM. Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death. J Natl Cancer Inst Monogr. 2014; 2014: 255 ‐ 264.
dc.identifier.citedreferenceTherneau T, Crowson C, Atkinson E. Multi‐state models and competing risks. Accessed December 13, 2017. https://cran.r‐project.org/web/packages/survival/vignettes/compete.pdf
dc.identifier.citedreferencePrentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics. 1978; 34: 541 ‐ 554.
dc.identifier.citedreferenceTherneau T, Crowson C, Atkinson E. Using time dependent covariates and time dependent coefficients in the Cox model. Accessed December 13, 2017. https://cran.r‐project.org/web/packages/survival/vignettes/timedep.pdf
dc.identifier.citedreferencede Boor C. A Practical Guide to Splines. Springer; 1978.
dc.identifier.citedreferenceWang W, Yan J. Package ‘splines2.’ Accessed June 15, 2018. https://cran.r‐project.org/web/packages/splines2/splines2.pdf
dc.identifier.citedreferenceKingma DP, Ba JL. Adam: a method for stochastic optimization. Accessed October 30, 2019. https://arxiv.org/pdf/1412.6980.pdf
dc.identifier.citedreferenceHe K, Zhu J, Kang J, Li Y. Minorization‐maximization‐based steepest ascent for large‐scale survival analysis with time‐varying effects: application to the National Kidney Transplant Dataset. Accessed February 17, 2020. https://arxiv.org/pdf/1912.12353.pdf
dc.identifier.citedreferenceDurrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989; 8: 551 ‐ 561.
dc.identifier.citedreferenceMozumder SI, Rutherford M, Lambert P. Direct likelihood inference on the cause‐specific cumulative incidence function: a flexible parametric regression modelling approach. Stat Med. 2018; 37: 82 ‐ 97.
dc.identifier.citedreferenceWang SJ, Wissel AR, Ord CB, et al. Individualized estimation of conditional survival for patients with head and neck cancer. Otolaryngol Head Neck Surg. 2011; 145: 71 ‐ 73.
dc.identifier.citedreferenceEmerick KS, Leavitt ER, Michaelson JS, Diephuis B, Clark JR, Deschler DG. Initial clinical findings of a mathematical model to predict survival of head and neck cancer. Otolaryngol Head Neck Surg. 2013; 149: 572 ‐ 578.
dc.identifier.citedreferenceCinciripini P. Smoking cessation in patients with cancer: treatment advances and the oncologist’s role. J Natl Compr Canc Netw. 2017; 15: 748 ‐ 750.
dc.identifier.citedreferenceJassem J. Declaration from IASLC: tobacco cessation after cancer diagnosis. Accessed March 2, 2020. https://www.iaslc.org/AboutIASLC/News‐Detail/declaration‐from‐iaslc‐tobacco‐cessation‐after‐cancer‐diagnosis
dc.identifier.citedreferenceRyan Camilon P, Stokes WA, Nguyen SA, Lentsch EJ. The prognostic significance of age in oropharyngeal squamous cell carcinoma. Oral Oncol. 2014; 50: 431 ‐ 436.
dc.identifier.citedreferenceFakhry C, Westra WH, Wang SJ, et al. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Cancer. 2017; 123: 1566 ‐ 1575.
dc.identifier.citedreferenceSettle K, Posner MR, Schumaker LM, et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in Black oropharyngeal cancer patients. Cancer Prev Res (Phila). 2009; 2: 776 ‐ 781.
dc.identifier.citedreferenceRagin CC, Langevin SM, Marzouk M, Grandis J, Taioli E. Determinants of head and neck cancer survival by race. Head Neck. 2011; 33: 1092 ‐ 1098.
dc.identifier.citedreferenceRyser MD, Lee WT, Ready NE, Leder KZ, Foo J. Quantifying the dynamics of field cancerization in tobacco‐related head and neck cancer: a multiscale modeling approach. Cancer Res. 2016; 76: 7078 ‐ 7088.
dc.identifier.citedreferenceLee DH, Roh JL, Baek S, et al. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 2013; 149: 579 ‐ 586.
dc.identifier.citedreferenceCenters for Disease Control and Prevention. 2014 Surgeon General’s Report: The Health Consequences of Smoking—50 Years of Progress. Accessed October 9, 2019. https://www.cdc.gov/tobacco/data_statistics/sgr/50th‐anniversary/index.htm
dc.identifier.citedreferenceSharp L, McDevitt J, Carsin AE, Brown C, Comber H. Smoking at diagnosis is an independent prognostic factor for cancer‐specific survival in head and neck cancer: findings from a large, population‐based study. Cancer Epidemiol Biomarkers Prev. 2014; 23: 2579 ‐ 2590.
dc.identifier.citedreferencePeterson LA, Bellile EL, Wolf GT, et al. Cigarette use, comorbidities, and prognosis in a prospective head and neck squamous cell carcinoma population. Head Neck. 2016; 38: 1810 ‐ 1820.
dc.identifier.citedreferenceMarur S, D’Souza G, Westra WH, Forastiere AA. HPV‐associated head and neck cancer: a virus‐related cancer epidemic. Lancet Oncol. 2010; 11: 781 ‐ 789.
dc.identifier.citedreferenceVigneswaran N, Williams MD. Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral Maxillofac Surg Clin North Am. 2014; 26: 123 ‐ 141.
dc.identifier.citedreferenceRettig EM, D’Souza G. Epidemiology of head and neck cancer. Surg Oncol Clin N Am. 2015; 24: 379 ‐ 396.
dc.identifier.citedreferenceLeemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018; 18: 269 ‐ 282.
dc.identifier.citedreferenceEgawa N, Egawa K, Griffin H, Doorbar J. Human papillomaviruses; epithelial tropisms, and the development of neoplasia. Viruses. 2015; 7: 3863 ‐ 3890.
dc.identifier.citedreferenceChaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29: 4294 ‐ 4301.
dc.identifier.citedreferenceWalline HM, Komarck C, McHugh JB, et al. High‐risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methods. JAMA Otolaryngol Head Neck Surg. 2013; 139: 1320 ‐ 1327.
dc.identifier.citedreferenceGillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus–positive head and neck squamous cell carcinoma. J Clin Oncol. 2015; 33: 3235 ‐ 3242.
dc.identifier.citedreferenceCombes JD, Franceschi S. Role of human papillomavirus in non‐oropharyngeal head and neck cancers. Oral Oncol. 2014; 50: 370 ‐ 379.
dc.identifier.citedreferenceNdiaye C, Mena M, Alemany L, et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta‐analysis. Lancet Oncol. 2014; 15: 1319 ‐ 1331.
dc.identifier.citedreferenceGillison ML, Alemany L, Snijders PJ, et al. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine. 2012; 30 ( suppl 5 ): F34 ‐ F54.
dc.identifier.citedreferenceSalazar CR, Anayannis N, Smith RV, et al. Combined P16 and human papillomavirus testing predicts head and neck cancer survival. Int J Cancer. 2014; 135: 2404 ‐ 2412.
dc.identifier.citedreferenceMahal BA, Catalano PJ, Haddad RI, et al. Incidence and demographic burden of HPV‐associated oropharyngeal head and neck cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2019; 28: 1660 ‐ 1667.
dc.identifier.citedreferenceCinciripini PM, Karam‐Hage M, Kypriotakis G, et al. Association of a comprehensive smoking cessation program with smoking abstinence among patients with cancer. JAMA Netw Open. 2019; 2: e1912251.
dc.identifier.citedreferenceSmith J, Nastasi D, Tso R, Vangaveti V, Renison B, Chilkuri M. The effects of continued smoking in head and neck cancer patients treated with radiotherapy: a systematic review and meta‐analysis. Radiother Oncol. 2019; 135: 51 ‐ 57.
dc.identifier.citedreferenceO’Sullivan B, Huang SH, Su J, et al. Development and validation of a staging system for HPV‐related oropharyngeal cancer by the International Collaboration on Oropharyngeal Cancer Network for Staging (ICON‐S): a multicentre cohort study. Lancet Oncol. 2016; 17: 440 ‐ 451.
dc.identifier.citedreferenceLydiatt WM, Patel SG, O’Sullivan B, et al. Head and neck cancers—major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017; 67: 122 ‐ 137.
dc.identifier.citedreferenceChoi SH, Terrell JE, Fowler KE, et al. Socioeconomic and other demographic disparities predicting survival among head and neck cancer patients. PLoS One. 2016; 11: e0149886.
dc.identifier.citedreferenceChang JH, Wu CC, Yuan KS, Wu ATH, Wu SY. Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes. Oncotarget. 2017; 8: 55600 ‐ 55612.
dc.identifier.citedreferenceGoodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope. 2000; 110 ( 3 pt 2 suppl 93 ): 1 ‐ 18.
dc.identifier.citedreferenceJayaram SC, Muzaffar SJ, Ahmed I, Dhanda J, Paleri V, Mehanna H. Efficacy, outcomes, and complication rates of different surgical and nonsurgical treatment modalities for recurrent/residual oropharyngeal carcinoma: a systematic review and meta‐analysis. Head Neck. 2016; 38: 1855 ‐ 1861.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cncr33174-sup-0001-FigS1-S4.pdf
Size:
221.2KB
Format:
PDF
View/Open
Name:
cncr33174.pdf
Size:
599.6KB
Format:
PDF
View/Open
Name:
cncr33174_am.pdf
Size:
668.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.